Medical Facilities Corporation
TSX:DR.TOMedical - Care Facilities
+$0.18 today
- Market cap
- $282.59M
- Beta
- 0.34
- P/E (TTM)
- 8.7
- EPS (TTM)
- $1.47
- Dividend yield
- 2.00%
Volume 0.04M
Average 0.02M
DR.TO Operating Cash Flow
Cash generated by the company's core business operations during the period.
Medical Facilities CorporationTSX: DR.TO
Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Operating cash flow declines year over year
Q1 FY2026 operating cash flow of $13.9M fell 11.8% year over year, ahead of the -34.4% change in trailing-twelve-month operating cash flow. Sequentially, it fell 2.4% from the prior quarter. Over 3 fiscal years it compounded at -6.9% a year.
Context
- Operating cash flow amounted to 17.8% of revenue in FY2025, down 7.4 pp from a year earlier.
- Operating cash flow increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -11.8% holds above the trailing-twelve-month pace of -34.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 45.95M USD
- Year-over-year change
- -44.8%
- 4-year CAGR
- -11.7%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 45.95M | -44.8% |
| FY2024 | 2024-12-31 | 83.28M | +14.5% |
| FY2023 | 2023-12-31 | 72.71M | +27.5% |
| FY2022 | 2022-12-31 | 57.01M | -24.6% |
| FY2021 | 2021-12-31 | 75.64M | — |
Operating Cash Flow vs competitors
How DR.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so operating cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -34.4% is the 6th highest of 9, against a peer median of -24.2%.
- Operating cash flow amounts to 16.0% of revenue for DR.TO, versus a peer median of 15.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$70.9M CAD | -57.2% | -51.4% | 22.8% | |
| LTM Mar 2026 | $48.89M USD | -34.4% | -6.9% | 16.0% | |
PRN.TOProfound Medical Corp. | LTM Mar 2026 | $38.32M USD | +43.9% | +14.6% | 204.3% |
| LTM Mar 2026 | CA$35.98M CAD | +71.5% | — | 22.7% | |
| LTM Mar 2026 | $31.41M USD | +15.5% | +15.7% | — | |
| LTM Mar 2026 | CA$28.14M CAD | -15.1% | +7.2% | 7.5% | |
| LTM Mar 2026 | $22.04M USD | -33.2% | — | 8.4% | |
| LTM Mar 2026 | CA$9.01M CAD | -42.3% | — | 3.3% | |
| LTM Mar 2026 | $7.86M USD | -52.0% | -6.7% | 15.4% | |
| Peer median (excluding DR.TO) | — | -24.2% | +7.2% | 15.4% | |
Competitors are the stored peer set for DR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 46.49M | 12.3M | 44M | 105.56M | 21.08M |
| Depreciation & Amortization | 26.77M | 20.76M | 21.54M | 19.37M | 15.66M |
| Deferred Income Tax | 4.4M | 5.21M | 8.33M | (3.67M) | 6.01M |
| Stock-Based Compensation | 292K | (667K) | (397K) | (246K) | 0 |
| Change in Working Capital | (10.45M) | (6.21M) | (488K) | (1.64M) | (3.96M) |
| Accounts Receivables | (1.23M) | (2.6M) | 1.03M | 5.23M | (4.02M) |
| Inventory | 659K | 1.42M | (205K) | (476K) | (659.34K) |
| Accounts Payables | (525K) | 2.46M | (2.48M) | (495K) | 1.86M |
| Other Working Capital | (9.35M) | (7.5M) | 1.17M | (5.9M) | (1.14M) |
| Other Non-Cash Items | 8.14M | 25.63M | (183K) | (36.09M) | 7.16M |
| Operating Cash Flow | 75.64M | 57.01M | 72.71M | 83.28M | 45.95M |
| Capital Expenditures | (8.42M) | (6.72M) | (16.05M) | (7.07M) | (4.96M) |
| Acquisitions (Net) | (267K) | 943K | 2.39M | 92.49M | 826.21K |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (267K) | 943K | 2.39M | 0 | 0 |
| Investing Cash Flow | (8.69M) | (5.78M) | (13.67M) | 85.42M | (4.14M) |
| Debt Repayment | (30.05M) | (6.47M) | (28.84M) | (32.82M) | (2.62M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (2.07M) | (38.38M) | (7.42M) | (16.61M) | (64.78M) |
| Dividends Paid | (6.92M) | (7.5M) | (6.07M) | (6.1M) | (5.18M) |
| Other Financing Activities | (33.02M) | (25M) | (27.49M) | (28.73M) | (34.72M) |
| Financing Cash Flow | (72.06M) | (77.35M) | (69.83M) | (84.26M) | (107.3M) |
| Effect of Forex Changes | (34K) | (3K) | (34K) | (59K) | (4.77M) |
| Net Change in Cash | (5.14M) | (26.12M) | (10.81M) | 84.38M | (70.26M) |
| Free Cash Flow | 67.22M | 50.3M | 56.66M | 76.22M | 40.99M |
Medical Facilities Corporation
TSX:DR.TO
Intrinsic Alpha fair value
Locked
Current Price
$17.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.